利格列汀杂质H

CAS No. 1646355-34-1

Linagliptin Impurity H

利格列汀杂质H

CAS No. 1646355-34-1

BRIGATINIB 中间体

CAS No. 1089279-90-2

1-(5-Methoxy-2-Methyl-4-nitrophenyl)-N,N-diMethylpiperidin-4-aMine

BRIGATINIB 中间体

CAS No. 1089279-90-2

吉非替尼杂质

CAS No. 1608115-59-8

Gefitinib iMpurity

吉非替尼杂质

CAS No. 1608115-59-8

达比加群乙二酸杂质I

CAS No. 255706-13-9

Dabigatran Etexilate iMpurity I

达比加群乙二酸杂质I

CAS No. 255706-13-9

利格列汀杂质K

CAS No. 1638744-06-5

Linagliptin Impurity K

利格列汀杂质K

CAS No. 1638744-06-5

依托考昔杂质10

CAS No. 316149-01-6

Etoricoxib Impurity 10

依托考昔杂质10

CAS No. 316149-01-6

达比加群杂质F

CAS No. 1642853-67-5

Dabigatran iMpurity F

达比加群杂质F

CAS No. 1642853-67-5

间位帕瑞昔布

CAS No. 1709956-89-7

Parecoxib Sodium Impurity 14

间位帕瑞昔布

CAS No. 1709956-89-7

依度沙班杂质

CAS No. 767625-11-6

2-(((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetic acid

依度沙班杂质

CAS No. 767625-11-6

利格列汀杂质F

CAS No. 1673546-62-7

Linagliptin Impurity F

利格列汀杂质F

CAS No. 1673546-62-7

利拉利汀杂质E

CAS No. 1446263-38-2

Linagliptin iMpurity E

利拉利汀杂质E

CAS No. 1446263-38-2

托法替尼杂质

CAS No. 477600-76-3

3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)

托法替尼杂质

CAS No. 477600-76-3

R-阿法替尼

CAS No. 945553-91-3

R-afatinib

R-阿法替尼

CAS No. 945553-91-3

达比加群乙二酸杂质R

CAS No. 1610758-20-7

Dabigatran etexilate Impurity R

达比加群乙二酸杂质R

CAS No. 1610758-20-7

达比加群杂质L

CAS No. 1422435-41-3

Dabigatran iMpurity L

达比加群杂质L

CAS No. 1422435-41-3

4-(4-氨基-3-氯苯氧基)-7-甲氧基喹啉-6-羧酸

CAS No. 417722-93-1

4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide

4-(4-氨基-3-氯苯氧基)-7-甲氧基喹啉-6-羧酸

CAS No. 417722-93-1

尼达尼布I杂质

CAS No. 334951-61-0

Nintedanib impurity I

尼达尼布I杂质

CAS No. 334951-61-0

对氨基苯甲酸

CAS No. 150-13-0

4-Aminobenzoic acid

对氨基苯甲酸

CAS No. 150-13-0

氰酸苯酯

CAS No. 1122-85-6

phenyl cyanate

氰酸苯酯

CAS No. 1122-85-6

2',4'-二甲基乙酰苯胺

CAS No. 2050-43-3

2',4'-DIMETHYLACETANILIDE

2',4'-二甲基乙酰苯胺

CAS No. 2050-43-3